Novo Nordisk partners with Vivtex in up to $2.1 billion deal for oral obesity drugs - Reuters

Reuters | Feb. 25, 2026, 8:03 a.m. | Original
Novo Nordisk partners with Vivtex in up to $2.1 billion deal for oral obesity drugs Reuters
Novartis to build radioligand therapy site in Texas to expand US manufacturing - Reuters OPEC+ to consider 137,000 bpd oil output increase for April, sources say - Reuters